Page last updated: 2024-11-01

nialamide and Labyrinth Diseases

nialamide has been researched along with Labyrinth Diseases in 1 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Labyrinth Diseases: Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erlach, A1

Other Studies

1 other study available for nialamide and Labyrinth Diseases

ArticleYear
[Clinical studies of cochleotoxicosis due to viomycin and kanamycin during tuberculostatic treatment (a prophylactic attempt)].
    Monatsschrift fur Ohrenheilkunde und Laryngo-Rhinologie, 1968, Volume: 102, Issue:11

    Topics: Adult; Aged; Audiometry; Cochlea; Deafness; Humans; Kanamycin; Labyrinth Diseases; Male; Nialamide;

1968